{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:12:08Z","timestamp":1779804728344,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH116046"],"award-info":[{"award-number":["R01 MH116046"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG066468"],"award-info":[{"award-number":["P30 AG066468"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40263-026-01286-9","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:15:41Z","timestamp":1774710941000},"page":"823-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer\u2019s Disease: A Real\u2011World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Chen","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Krivinko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-9967","authenticated-orcid":false,"given":"Lirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.Ad19038br1c","author":"D Aarsland","year":"2020","unstructured":"Aarsland D. Epidemiology and pathophysiology of dementia-related psychosis. J Clin Psychiatry. 2020. https:\/\/doi.org\/10.4088\/jcp.Ad19038br1c.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1286_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008. Pharmacoepidemiol Drug Saf. 2011;20(2):177\u201384. https:\/\/doi.org\/10.1002\/pds.2082.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1286_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40266-022-00992-5","volume":"40","author":"M Rogowska","year":"2023","unstructured":"Rogowska M, Thornton M, Creese B, et al. Implications of adverse outcomes associated with antipsychotics in older patients with dementia: a 2011\u20132022 update. Drugs Aging. 2023;40(1):21\u201332. https:\/\/doi.org\/10.1007\/s40266-022-00992-5.","journal-title":"Drugs Aging"},{"key":"1286_CR4","unstructured":"U.S. Food and Drug Administration (FDA). Public health advisory: deaths with antipsychotics in elderly patients with behavioral disturbances. 2005. Available from: https:\/\/wayback.archive-it.org\/7993\/20170113112252\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm053171.htm. Accessed 5 Feb 2026."},{"key":"1286_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076268","volume":"385","author":"PLH Mok","year":"2024","unstructured":"Mok PLH, Carr MJ, Guthrie B, et al. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ. 2024;385:e076268. https:\/\/doi.org\/10.1136\/bmj-2023-076268.","journal-title":"BMJ"},{"issue":"1","key":"1286_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/adr-170042","volume":"2","author":"SJ Ralph","year":"2018","unstructured":"Ralph SJ, Espinet AJ. Increased all-cause mortality by antipsychotic drugs: updated review and meta-analysis in dementia and general mental health care. J Alzheimers Dis Rep. 2018;2(1):1\u201326. https:\/\/doi.org\/10.3233\/adr-170042.","journal-title":"J Alzheimers Dis Rep"},{"key":"1286_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.631770","volume":"13","author":"JA Santiago","year":"2021","unstructured":"Santiago JA, Potashkin JA. The impact of disease comorbidities in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13:631770. https:\/\/doi.org\/10.3389\/fnagi.2021.631770.","journal-title":"Front Aging Neurosci"},{"issue":"9596","key":"1286_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/s0140-6736(07)61602-x","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(07)61602-x.","journal-title":"Lancet"},{"issue":"3","key":"1286_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/pds.5567","volume":"32","author":"C Bharat","year":"2023","unstructured":"Bharat C, Degenhardt L, Pearson SA, et al. A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data. Pharmacoepidemiol Drug Saf. 2023;32(3):352\u201365. https:\/\/doi.org\/10.1002\/pds.5567.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1286_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3342","volume":"370","author":"KB Filion","year":"2020","unstructured":"Filion KB, Lix LM, Yu OH, et al. Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study. BMJ. 2020;370:m3342. https:\/\/doi.org\/10.1136\/bmj.m3342.","journal-title":"BMJ"},{"issue":"2","key":"1286_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-079347","volume":"14","author":"MT Bjelkar\u00f8y","year":"2024","unstructured":"Bjelkar\u00f8y MT, Simonsen TB, Siddiqui TG, et al. Mortality and health-related quality of life in older adults with long-term use of opioids, z-hypnotics or benzodiazepines: a prospective observational study at 5 years follow-up. BMJ Open. 2024;14(2):e079347. https:\/\/doi.org\/10.1136\/bmjopen-2023-079347.","journal-title":"BMJ Open"},{"issue":"12","key":"1286_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28557","volume":"3","author":"KY Xu","year":"2020","unstructured":"Xu KY, Hartz SM, Borodovsky JT, et al. Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999\u20132015. JAMA Netw Open. 2020;3(12):e2028557-e. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28557.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1286_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00228-019-02795-x","volume":"76","author":"S Ali","year":"2020","unstructured":"Ali S, Peterson GM, Bereznicki LR, et al. Association between anticholinergic drug burden and mortality in older people: a systematic review. Eur J Clin Pharmacol. 2020;76(3):319\u201335. https:\/\/doi.org\/10.1007\/s00228-019-02795-x.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"1286_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archinternmed.2008.525","volume":"169","author":"GH Gislason","year":"2009","unstructured":"Gislason GH, Rasmussen JN, Abildstrom SZ, et al. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med. 2009;169(2):141\u20139. https:\/\/doi.org\/10.1001\/archinternmed.2008.525.","journal-title":"Arch Intern Med"},{"issue":"8","key":"1286_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","volume":"42","author":"D Ho","year":"2011","unstructured":"Ho D, Imai K, King G, et al. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1\u201328. https:\/\/doi.org\/10.18637\/jss.v042.i08.","journal-title":"J Stat Softw"},{"issue":"523","key":"1286_CR16","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","volume":"113","author":"S Wager","year":"2018","unstructured":"Wager S, Athey S. Estimation and inference of heterogeneous treatment effects using random forests. J Am Stat Assoc. 2018;113(523):1228\u201342. https:\/\/doi.org\/10.1080\/01621459.2017.1319839.","journal-title":"J Am Stat Assoc"},{"key":"1286_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v051.i13","volume":"51","author":"S Gruber","year":"2012","unstructured":"Gruber S, Van Der Laan M. tmle: an R package for targeted maximum likelihood estimation. J Stat Softw. 2012;51:1\u201335. https:\/\/doi.org\/10.18637\/jss.v051.i13.","journal-title":"J Stat Softw"},{"key":"1286_CR18","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1309","volume":"6","author":"MJ van der Laan","year":"2007","unstructured":"van der Laan MJ, Polley EC, Hubbard AE. Super learner. Stat Appl Genet Mol Biol. 2007;6:Article25. https:\/\/doi.org\/10.2202\/1544-6115.1309.","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"9","key":"1286_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/156720512803569037","volume":"9","author":"V Gardette","year":"2012","unstructured":"Gardette V, Lapeyre-Mestre M, Coley N, et al. Antipsychotic use and mortality risk in community-dwelling Alzheimer\u2019s disease patients: evidence for a role of dementia severity. Curr Alzheimer Res. 2012;9(9):1106\u201316. https:\/\/doi.org\/10.2174\/156720512803569037.","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"1286_CR20","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.euroneuro.2015.08.014","volume":"25","author":"P Jennum","year":"2015","unstructured":"Jennum P, Baandrup L, Ibsen R, et al. Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study. Eur Neuropsychopharmacol. 2015;25(11):1906\u201313. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.08.014.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"1286_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/acps.12614","volume":"134","author":"RE Nielsen","year":"2016","unstructured":"Nielsen RE, Lolk A, Valentin JB, et al. Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer\u2019s dementia. Acta Psychiatr Scand. 2016;134(4):314\u201320. https:\/\/doi.org\/10.1111\/acps.12614.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1286_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1176\/appi.ajp.2011.11030347","volume":"169","author":"HC Kales","year":"2012","unstructured":"Kales HC, Kim HM, Zivin K, et al. Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry. 2012;169(1):71\u20139. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11030347.","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1286_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1532-5415.2010.02873.x","volume":"58","author":"RC Rossom","year":"2010","unstructured":"Rossom RC, Rector TS, Lederle FA, et al. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia? J Am Geriatr Soc. 2010;58(6):1027\u201334. https:\/\/doi.org\/10.1111\/j.1532-5415.2010.02873.x.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1286_CR24","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s12325-022-02075-8","volume":"39","author":"I Yunusa","year":"2022","unstructured":"Yunusa I, Rashid N, Demos GN, et al. Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: a network meta-analysis. Adv Ther. 2022;39(5):1993\u20132008. https:\/\/doi.org\/10.1007\/s12325-022-02075-8.","journal-title":"Adv Ther"},{"key":"1286_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2024-301019","author":"W L\u00fc","year":"2024","unstructured":"L\u00fc W, Liu F, Zhang Y, et al. Efficacy, acceptability and tolerability of second-generation antipsychotics for behavioural and psychological symptoms of dementia: a systematic review and network meta-analysis. BMJ Ment Health. 2024. https:\/\/doi.org\/10.1136\/bmjment-2024-301019.","journal-title":"BMJ Ment Health"},{"issue":"4","key":"1286_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40263-013-0054-1","volume":"27","author":"G Scigliano","year":"2013","unstructured":"Scigliano G, Ronchetti G. Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis. CNS Drugs. 2013;27(4):249\u201357. https:\/\/doi.org\/10.1007\/s40263-013-0054-1.","journal-title":"CNS Drugs"},{"key":"1286_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1361772","volume":"16","author":"L Liu","year":"2024","unstructured":"Liu L, Gracely EJ, Zhao X, et al. Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer\u2019s disease and AD-related dementia or cognitive decline: a prospective cohort study. Front Aging Neurosci. 2024;16:1361772. https:\/\/doi.org\/10.3389\/fnagi.2024.1361772.","journal-title":"Front Aging Neurosci"},{"key":"1286_CR28","unstructured":"Gettu N SA. Aripiprazole. Updated 2023 May 16. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547739\/. Accessed 5 Feb 2026."},{"issue":"1","key":"1286_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/13696998.2021.2019501","volume":"25","author":"A Kadakia","year":"2022","unstructured":"Kadakia A, Brady BL, Dembek C, et al. The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population. J Med Econ. 2022;25(1):87\u201398. https:\/\/doi.org\/10.1080\/13696998.2021.2019501.","journal-title":"J Med Econ"},{"issue":"8","key":"1286_CR30","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1185\/03007995.2014.908280","volume":"30","author":"L Citrome","year":"2014","unstructured":"Citrome L, Kalsekar I, Baker RA, et al. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Curr Med Res Opin. 2014;30(8):1629\u201341. https:\/\/doi.org\/10.1185\/03007995.2014.908280.","journal-title":"Curr Med Res Opin"},{"key":"1286_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1617534","volume":"16","author":"YT Yeh","year":"2025","unstructured":"Yeh YT, Lo SC, Huang CN, et al. Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study. Front Pharmacol. 2025;16:1617534. https:\/\/doi.org\/10.3389\/fphar.2025.1617534.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1286_CR32","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","volume":"59","author":"R Brookmeyer","year":"2002","unstructured":"Brookmeyer R, Corrada MM, Curriero FC, et al. Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002;59(11):1764\u20137. https:\/\/doi.org\/10.1001\/archneur.59.11.1764.","journal-title":"Arch Neurol"},{"key":"1286_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080636","volume":"388","author":"CC Br\u00fcck","year":"2025","unstructured":"Br\u00fcck CC, Mooldijk SS, Kuiper LM, et al. Time to nursing home admission and death in people with dementia: systematic review and meta-analysis. BMJ. 2025;388:e080636. https:\/\/doi.org\/10.1136\/bmj-2024-080636.","journal-title":"BMJ"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01286-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:38:43Z","timestamp":1779802723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-026-01286-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01286-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Conceptualization: Chen Jiang, Lirong Wang; methodology: Chen Jiang, Lang Zeng, Ying Ding, Lirong Wang; formal analysis and investigation: Chen Jiang, Zeshui Yu, Zheng Zeng; data curation: Hui Wang, Zeshui Yu, Zheng Zeng; writing\u2014original draft: Chen Jiang; writing\u2014review and editing: Chen Jiang, Josh Krivinko, Zeshui Yu, Robert A. Sweet, Lang Zeng, Hui Wang, Ying Ding, Zheng Zeng, Julia Kofler, Lirong Wang; supervision: Lirong Wang; all authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"This study used deidentified electronic health records provided by Truveta. Institutional Review Board approval was waived for this retrospective analysis of deidentified data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was not required as the study used deidentified data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The data that support the findings of this study are available from Truveta under a data use agreement. These data are not publicly available due to licensing restrictions. Access to the data may be granted by Truveta upon reasonable request and subject to their data sharing policies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}